Pfizer’s Kaurona Vaccine Discovered 95% Effective in Phase III Clinical Trials

Pfizer’s Kaurona vaccine turns out to be 95 percent effective in Phase III clinical trials

0) {setTimeout (function () {body.item (0) .classList.remove (‘styles-loading’);}, 10);} “>


Last update
Nov 18, 2020, 06:28 pm



Source link